1st Quarter - Report

TIBER CREEK HEALTH STRATEGIES, INC. for DAIICHI SANKYO, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Work related to a specific patent issue affecting Daiichi Sankyo.

Foreign entity interest: To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.

LobbyistCovered position, as disclosed
JAMES BRYANT HALL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Matters relating to the pharmaceutical and health care industries/patents.

Foreign entity interest: To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.

LobbyistCovered position, as disclosed
JAMES BRYANT HALL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

Matters relating to the pharmaceutical and health care industries/patents.

Foreign entity interest: To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.

LobbyistCovered position, as disclosed
JAMES BRYANT HALL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Matters relating to the pharmaceutical and health care industries/patents.

Foreign entity interest: To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.

LobbyistCovered position, as disclosed
JAMES BRYANT HALL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.